For a person under 55, a stroke is often a bolt from the blue. It frequently stems from a cervical artery dissection—a tear in the artery walls that feed the brain—which can occur without warning, often in people with no obvious risk factors. Now, researchers at the University of Virginia have identified a distinct, temporary "signature" of gene activity that appears during these events, offering a potential new path toward prevention.

Cervical artery dissections are responsible for one in five strokes in younger adults. While some cases are linked to minor neck trauma or underlying genetic disorders, the majority are classified as spontaneous. This ambiguity has long frustrated clinicians, as there has been no reliable way to predict who might be at risk.

The Hemoglobin Connection

To investigate the biological triggers of these arterial tears, the UVA team compared 37 patients who had recently suffered a dissection against a control group of healthy volunteers. The results, published in Neurology Genetics, revealed that patients exhibited significant differences in the activity of 11 specific genes immediately following their dissections compared to the healthy participants.

Perhaps most importantly, this gene-activation pattern was transient. When researchers checked the patients again at a later stage, the gene activity had shifted, suggesting the signature is a temporary response to the injury or a precursor to the event itself.

Most of the identified genes were linked to the body’s processing of hemoglobin. While hemoglobin is primarily known for transporting oxygen, it also plays a critical role in blood clotting. The researchers hypothesize that impaired oxygen transport or abnormal hemoglobin activity may create systemic conditions that leave arterial walls vulnerable to tearing.

Why the Timing Matters

Identifying a genetic marker that exists only during the early phase of a dissection is a significant shift in how researchers approach stroke prevention. If doctors can identify the biological precursors to these tears, they might eventually be able to intervene before the artery actually ruptures.

"Understanding the genetic and environmental risk factors associated with cervical artery dissection takes us a step closer to identifying those at most risk and, ideally, preventing it from occurring," said Dr. Andrew M. Southerland, a stroke expert at the University of Virginia School of Medicine.

However, the team emphasizes that these findings are in the early stages. The sample size of 37 patients is small, and the results must be validated in larger, more diverse cohorts before they can be translated into clinical tools or diagnostic tests.

What Experts Say

Researchers involved in the study are already moving to the next phase of investigation. The team is currently coordinating with an international network of collaborators to determine if this hemoglobin-related gene signature appears consistently across different populations.

"This work remains highly preliminary, and we need to replicate it in other larger and more diverse groups of patients," Southerland noted. The goal is to move from observing these patterns to understanding the underlying mechanisms that cause the arteries to fail in the first place.

Key Takeaways

  • Cervical artery dissections account for 20 percent of strokes in people under 55, often occurring without warning or clear cause.
  • A new study identified 11 genes that show abnormal activity immediately following a dissection, most of which are involved in hemoglobin regulation.
  • The gene signature is temporary, suggesting it could serve as a specific biomarker for the early stages of an arterial event.

As the research team expands its study to international cohorts, the next major milestone will be determining whether these gene patterns can be detected in patients before a dissection occurs. If the signature proves to be a reliable predictor, it could eventually lead to a screening test for high-risk individuals, potentially sparing thousands of young adults from life-altering disability. The team expects to release data from their expanded international study within the next 18 to 24 months.

This article is for informational purposes only. Always consult a qualified healthcare professional before making any medical decisions.